Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novocure Ltd Ord Sh
(NQ:
NVCR
)
21.99
-0.18 (-0.81%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novocure Ltd Ord Sh
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2022
February 08, 2022
Upgrades According to Consumer Edge Research, the prior rating for The Hain Celestial Group Inc (NASDAQ:HAIN) was changed from Equal-Weight to Overweight. For the second...
Via
Benzinga
World Markets News
January 20, 2022
Today oil and gas inventories were seen as higher than expected while potential prices fell, both bullish.
Via
Talk Markets
Cramer Gives His Opinion On Novocure, InMode, Virgin Galactic And More
January 12, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Atkore (NASDAQ:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
February 02, 2022
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09...
Via
Benzinga
Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer
January 10, 2022
Pfizer and Bayer inked deals with several companies in gene-editing.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022
January 20, 2022
Upgrades For W.P. Carey Inc (NYSE:WPC), B...
Via
Benzinga
Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company Update
January 10, 2022
From
Novocure
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
January 06, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...
Via
Benzinga
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich
Via
InvestorPlace
Novocure to Participate in the 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022
From
Novocure
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a...
Via
Benzinga
Start Of 2022
January 03, 2022
Mohammed El Erien predicts that the Fed will be slamming on the brakes this year.
Via
Talk Markets
Stocks Hitting New 52-Week Lows Today
January 03, 2022
On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was...
Via
Benzinga
Happy New Year - Sunday Edition
January 02, 2022
Starting a new year - we look at tech, pharma and mining stocks and their goings-on.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
January 03, 2022
Upgrades For nVent Electric PLC (NYSE:NVT), Vertica...
Via
Benzinga
Market Trend: Erratic And Unreliable
December 29, 2021
Given the risks of covid variants and hefty price rises, the stock market should not be as buoyant as it is.
Via
Talk Markets
Plague Year Reversal
December 21, 2021
Just in time for Christmas, the market decided to go up today pretty much across the board.
Via
Talk Markets
Inflation Surge
December 10, 2021
Today the market failed to brush off inflation fears as it had done later on Thursday as inflation is at a 4 decade high.
Via
Talk Markets
Novocure Signs Agreement to Acquire and Construct Building in Downtown Portsmouth, New Hampshire
December 07, 2021
From
Novocure
Via
Business Wire
recession in 2022?
December 06, 2021
China has cut its reserve requirement for lending by 50% giving a $188 bn boost to its market.
Via
Talk Markets
Topics
Economy
Exposures
Economy
Novocure Announces 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
December 06, 2021
From
Novocure
Via
Business Wire
Charms Of China
December 03, 2021
Today the global stock market rout was pretty awful.
Via
Talk Markets
Is It Time to Buy the 3 Worst-Performing Growth Stocks of 2021?
December 03, 2021
This year's big pullbacks are more the result of a raucous 2020, and less an indictment of these companies' prospects.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Tuesday Markets Review
November 30, 2021
The oil price did not fall as expected over the White House release of 50 mn bbls of oil.
Via
Talk Markets
Tuesday Markets Coverage
November 23, 2021
GE was up on hopes for cheaper oil. But most stocks were down on oil price hike fears.
Via
Talk Markets
Novocure to Participate in Two Upcoming Investor Conferences
November 23, 2021
From
Novocure
Via
Business Wire
Novocure Announces Last Patient Enrolled in Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-small Cell Lung Cancer
November 22, 2021
From
Novocure
Via
Business Wire
Novocure Posts Data For Tumor Treating Fields In Brain Tumor Trial
November 15, 2021
Novocure Ltd (NASDAQ: NVCR) has released updated data from the Phase 2 pilot 2-THE-TOP of Tumor Treating Fields (TTFields) together with pembrolizumab and...
Via
Benzinga
2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed Glioblastoma
November 15, 2021
From
Novocure
Via
Business Wire
Novocure Announces 31 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2021 Annual Meeting
November 15, 2021
From
Novocure
Via
Business Wire
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.